Citadel Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-51,221
Closed -$309K 5609
2019
Q4
$309K Sell
51,221
-992,429
-95% -$5.99M ﹤0.01% 3851
2019
Q3
$3.76M Sell
1,043,650
-1,079,698
-51% -$3.89M ﹤0.01% 1875
2019
Q2
$5.69M Sell
2,123,348
-974,958
-31% -$2.61M ﹤0.01% 1564
2019
Q1
$9.17M Sell
3,098,306
-2,388,788
-44% -$7.07M ﹤0.01% 1177
2018
Q4
$8.73M Buy
5,487,094
+1,311,839
+31% +$2.09M ﹤0.01% 1095
2018
Q3
$15.4M Sell
4,175,255
-504,569
-11% -$1.86M 0.01% 881
2018
Q2
$13.2M Buy
4,679,824
+1,805,261
+63% +$5.11M 0.01% 890
2018
Q1
$10.7M Buy
2,874,563
+2,139,919
+291% +$7.94M 0.01% 914
2017
Q4
$2.12M Buy
734,644
+633,626
+627% +$1.83M ﹤0.01% 1868
2017
Q3
$453K Sell
101,018
-80,951
-44% -$363K ﹤0.01% 2747
2017
Q2
$835K Buy
181,969
+25,767
+16% +$118K ﹤0.01% 2276
2017
Q1
$658K Sell
156,202
-154,299
-50% -$650K ﹤0.01% 2416
2016
Q4
$1.28M Buy
310,501
+18,425
+6% +$76.1K ﹤0.01% 1807
2016
Q3
$2.37M Buy
292,076
+193,451
+196% +$1.57M ﹤0.01% 1454
2016
Q2
$769K Sell
98,625
-245,462
-71% -$1.91M ﹤0.01% 1987
2016
Q1
$2.66M Sell
344,087
-187,493
-35% -$1.45M ﹤0.01% 1284
2015
Q4
$5.74M Sell
531,580
-140,246
-21% -$1.51M 0.01% 1058
2015
Q3
$4.64M Buy
671,826
+511,736
+320% +$3.54M ﹤0.01% 1261
2015
Q2
$1.42M Buy
160,090
+98,965
+162% +$877K ﹤0.01% 1928
2015
Q1
$602K Buy
61,125
+9,337
+18% +$92K ﹤0.01% 2504
2014
Q4
$635K Sell
51,788
-459,940
-90% -$5.64M ﹤0.01% 2402
2014
Q3
$5.11M Buy
511,728
+357,052
+231% +$3.56M 0.01% 1168
2014
Q2
$1.17M Buy
154,676
+138,513
+857% +$1.05M ﹤0.01% 1769
2014
Q1
$53K Sell
16,163
-45,053
-74% -$148K ﹤0.01% 3280
2013
Q4
$203K Sell
61,216
-117,940
-66% -$391K ﹤0.01% 2478
2013
Q3
$541K Buy
179,156
+110,497
+161% +$334K ﹤0.01% 1848
2013
Q2
$561K Buy
+68,659
New +$561K ﹤0.01% 1888